Chapter 4 – Adaptive Immunity and Autoimmunity: Translation from Bench to Bedside

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/B978-0-323-24145-8.00004-1
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Methotrexate-mediated inhibition of nuclear factor κB activation by distinct pathways in T cells and fibroblast-like synoviocytes.

  2015cited by this paper
• T Cell Expression of Granulocyte–Macrophage Colony-Stimulating Factor in Juvenile Arthritis Is Contingent Upon Th17 Plasticity

  2014cited by this paper
• Staying innate: transcription factor maintenance of innate lymphoid cell identity

  2014cited by this paper
• Genome-Wide Data reveals Novel Genes for Methotrexate Response in a Large Cohort of Juvenile Idiopathic Arthritis Cases

  2014cited by this paper
• Methotrexate in juvenile idiopathic arthritis: towards tailor-made treatment

  2014cited by this paper
• B‐type suppression: A role played by “regulatory B cells” or “regulatory plasma cells”?

  2014cited by this paper
• The genetics of juvenile idiopathic arthritis: current understanding and future prospects.

  2014cited by this paper
• A115: Deep Immunophenotyping in the Identification of Clinically Meaningful Immune Signatures in Juvenile Idiopathic Arthritis

  2014cited by this paper
• From the regulatory functions of B cells to the identification of cytokine-producing plasma cell subsets.

  2014cited by this paper
• A sensitive protocol for FOXP3 epigenetic analysis in scarce human samples

  2014cited by this paper
• Interleukin-35 takes the 'B' line

  2014cited by this paper
• Tofacitinib versus methotrexate in rheumatoid arthritis.

  2014cited by this paper
• Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications.

  2014cited by this paper
• The BAFF/APRIL system in SLE pathogenesis

  2014cited by this paper
• Unraveling the soul of autoimmune diseases: pathogenesis, diagnosis and treatment adding dowels to the puzzle

  2013cited by this paper
• Fms-Like Tyrosine Kinase 3 Ligand Controls Formation of Regulatory T Cells in Autoimmune Arthritis

  2013cited by this paper
• Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis

  2013cited by this paper
• Adult and juvenile dermatomyositis: are the distinct clinical features explained by our current understanding of serological subgroups and pathogenic mechanisms?

  2013cited by this paper
• A subgroup of juvenile idiopathic arthritis patients who respond well to methotrexate are identified by the serum biomarker MRP8/14 protein.

  2013cited by this paper
• The Th17 family: flexibility follows function

  2013cited by this paper
• CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines.

  2013cited by this paper
• The effect of autoimmune arthritis treatment strategies on regulatory T-cell dynamics

  2013cited by this paper
• A Mathematical Model of Immune Activation with a Unified Self-Nonself Concept

  2013cited by this paper
• Update in juvenile myositis

  2013cited by this paper
• NF‐κB: roles and regulation in different CD4+ T‐cell subsets

  2013cited by this paper
• Metabolic control of the Treg/Th17 axis

  2013cited by this paper
• CD19+CD24hiCD38hi B Cells Maintain Regulatory T Cells While Limiting TH1 and TH17 Differentiation

  2013cited by this paper
• 106 – Etiology and Pathogenesis of Juvenile Idiopathic Arthritis

  2013cited by this paper
• Treg Cells in Rheumatoid Arthritis: An Update

  2013cited by this paper
• Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis

  2013cited by this paper
• Hydroxychloroquine preferentially induces apoptosis of CD45RO+ effector T cells by inhibiting autophagy: a possible mechanism for therapeutic modulation of T cells.

  2013cited by this paper
• Heat shock protein bystander antigens for peptide immunotherapy in autoimmune disease

  2013cited by this paper
• Location, location, location: tissue‐specific regulation of immune responses

  2013cited by this paper
• T cell immunity as a tool for studying epigenetic regulation of cellular differentiation

  2013cited by this paper
• Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial.

  2013cited by this paper
• Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45RO+CD25+CD127low regulatory T cells

  2012cited by this paper
• T cell metabolism and the immune response.

  2012cited by this paper
• Tolerogenic function of Blimp-1 in dendritic cells

  2012cited by this paper
• Osteoarthritis synovial fluid activates pro-inflammatory cytokines in primary human chondrocytes

  2012cited by this paper
• Targeting the B7 Family of Co-Stimulatory Molecules

  2012cited by this paper
• Cellular Regulation of the Inflammatory Response

  2012cited by this paper
• Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus.

  2012cited by this paper
• Decisions about dendritic cells: past, present, and future.

  2012cited by this paper
• B effector cells in rheumatoid arthritis and experimental arthritis

  2012cited by this paper
• Helper T cell diversity and plasticity.

  2012cited by this paper
• Rheumatoid Fibroblast-like Synoviocytes Downregulate Foxp3 Expression by Regulatory T Cells Via GITRL/GITR Interaction

  2012cited by this paper
• Dendritic cells: arbiters of immunity and immunological tolerance.

  2012cited by this paper
• Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis

  2012cited by this paper
• Epitope-specific immune tolerization ameliorates experimental autoimmune encephalomyelitis.

  2012cited by this paper
• Elevated BAFF (BLyS) and APRIL in Juvenile idiopathic arthritis patients: relation to clinical manifestations and disease activity.

  2012cited by this paper
• The genomics of autoimmune disease in the era of genome-wide association studies and beyond.

  2012cited by this paper
• Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions

  2011cited by this paper
• Shaping the T‐cell repertoire: a matter of life and death

  2011cited by this paper
• Treating inflammation with the Janus kinase inhibitor CP-690,550.

  2011cited by this paper
• Dendritic cell expression of A20 preserves immune homeostasis and prevents colitis and spondyloarthritis

  2011cited by this paper
• Functional human regulatory T cells fail to control autoimmune inflammation due to PKB/c-akt hyperactivation in effector cells

  2011cited by this paper
• Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab).

  2011cited by this paper
• Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis

  2011cited by this paper
• Induction of immune tolerance in the treatment of rheumatoid arthritis

  2011cited by this paper
• Subtype specific genetic associations for juvenile idiopathic arthritis: ERAP1 with the enthesitis related arthritis subtype and IL23R with juvenile psoriatic arthritis

  2011cited by this paper
• Bystander suppression of experimental arthritis by nasal administration of a heat shock protein peptide

  2011cited by this paper
• Phenotypical and functional specialization of FOXP3+ regulatory T cells

  2011cited by this paper
• Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4

  2011cited by this paper
• Regulation of immunity and autoimmunity by B cells.

  2010cited by this paper
• CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.

  2010cited by this paper
• Identifying the Cells Breaching Self-Tolerance in Autoimmunity

  2010cited by this paper
• Regulatory T cells exert checks and balances on self tolerance and autoimmunity

  2010cited by this paper
• Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment

  2010cited by this paper
• Methotrexate—how does it really work?

  2010cited by this paper
• The need for personalised medicine for rheumatoid arthritis

  2010cited by this paper
• Bacterial peptides are intensively present throughout the human proteome.

  2010cited by this paper
• Therapeutic efficacy of experimental rheumatoid arthritis with low-dose methotrexate by increasing partially CD4+CD25+ Treg cells and inducing Th1 to Th2 shift in both cells and cytokines.

  2010cited by this paper
• Treatment of Autoimmune Arthritis Using RNA Interference-Modulated Dendritic Cells

  2010cited by this paper
• Regulatory T Cells Protect from Local and Systemic Bone Destruction in Arthritis

  2010cited by this paper
• Biologics and postbiologics: novel immunotherapeutics for the induction and maintenance of remission.

  2010cited by this paper
• Autoimmunity: increasing suspects in the CD4+ T cell lineup

  2010cited by this paper
• Differentiation of effector CD4 T cell populations (*).

  2010cited by this paper
• Biologic predictors of extension of oligoarticular juvenile idiopathic arthritis as determined from synovial fluid cellular composition and gene expression

  2010cited by this paper
• Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis.

  2009cited by this paper
• A Dual Action of Rheumatoid Arthritis Synovial Fibroblast IL-15 Expression on the Equilibrium between CD4+CD25+ Regulatory T Cells and CD4+CD25− Responder T Cells1

  2009cited by this paper
• Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial.

  2009cited by this paper
• Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice.

  2009cited by this paper
• IL-17-producing human peripheral regulatory T cells retain suppressive function.

  2009cited by this paper
• Heat Shock Protein-Derived T-Cell Epitopes Contribute to Autoimmune Inflammation in Pediatric Crohn's Disease

  2009cited by this paper
• Janus kinases in immune cell signaling

  2009cited by this paper
• Expansion of peripheral naturally occurring T regulatory cells by Fms-like tyrosine kinase 3 ligand treatment.

  2009cited by this paper
• Pediatric Rheumatology BioMed Central Review

  2008cited by this paper
• Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial.

  2008cited by this paper
• Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells

  2008cited by this paper
• Interleukin-17–producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers

  2008cited by this paper
• The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt

  2008cited by this paper
• Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.

  2008cited by this paper
• Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis

  2008cited by this paper
• Treg cells suppress osteoclast formation: a new link between the immune system and bone.

  2007cited by this paper
• Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells.

  2007cited by this paper
• Differential recognition of heat-shock protein dnaJ-derived epitopes by effector and Treg cells leads to modulation of inflammation in juvenile idiopathic arthritis.

  2007cited by this paper
• 1,25-Dihydroxyvitamin D3 Selectively Modulates Tolerogenic Properties in Myeloid but Not Plasmacytoid Dendritic Cells1

  2007cited by this paper
• Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia

  2005cited by this paper
• Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade

  2005cited by this paper
• [Juvenile idiopathic arthritis].

  2005cited by this paper

• Chapter 12 Immunotherapeutic Biologic Agents to Treat Autoinflammatory Diseases

  2018cites this paper
• Immunotherapeutic Biologic Agents to Treat Autoinflammatory Diseases

  2017cites this paper
• Immunotherapeutic Biologic Agents in Autoimmune and Autoinflammatory Diseases

  2015cites this paper